BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,039 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28,977,768 | -22.7% | 866,301 | -1.2% | 0.65% | -20.0% |
| Q1 2024 | $37,490,802 | +9.4% | 877,183 | -1.0% | 0.81% | +4.4% |
| Q4 2023 | $34,263,779 | +29.3% | 886,285 | +26.2% | 0.77% | +19.8% |
| Q3 2023 | $26,502,311 | -20.1% | 702,234 | -3.6% | 0.64% | -15.6% |
| Q2 2023 | $33,183,125 | +9.9% | 728,339 | -2.1% | 0.76% | +9.3% |
| Q1 2023 | $30,181,142 | -9.2% | 744,111 | +14.1% | 0.70% | -8.3% |
| Q4 2022 | $33,243,093 | -6.0% | 652,209 | -0.6% | 0.76% | -15.6% |
| Q3 2022 | $35,348,000 | -4.3% | 656,297 | +14.1% | 0.90% | +5.7% |
| Q2 2022 | $36,951,000 | +48.4% | 575,292 | +79.2% | 0.85% | +76.4% |
| Q1 2022 | $24,894,000 | +37.2% | 321,046 | -41.9% | 0.48% | +49.4% |
| Q3 2015 | $18,139,000 | -69.3% | 552,191 | -34.6% | 0.32% | -62.6% |
| Q2 2015 | $59,030,000 | -2.4% | 844,136 | -4.4% | 0.87% | +1.6% |
| Q1 2015 | $60,488,000 | -9.3% | 883,036 | -3.0% | 0.85% | -6.5% |
| Q4 2014 | $66,719,000 | -2.3% | 910,341 | -4.3% | 0.91% | -1.3% |
| Q3 2014 | $68,286,000 | -8.5% | 951,451 | -7.8% | 0.92% | +5.4% |
| Q2 2014 | $74,623,000 | -4.3% | 1,032,136 | -2.6% | 0.88% | -6.3% |
| Q1 2014 | $77,997,000 | +6.5% | 1,060,036 | +0.7% | 0.94% | +1.0% |
| Q4 2013 | $73,240,000 | +30.9% | 1,053,056 | +23.6% | 0.93% | +21.5% |
| Q3 2013 | $55,949,000 | -3.6% | 851,715 | +1.6% | 0.76% | -3.8% |
| Q2 2013 | $58,049,000 | – | 838,006 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
| NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
| Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
| Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
| GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
| Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
| Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
| Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
| Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |